D-128-2013 Class III Terminated

Recalled by Teva Pharmaceuticals USA, Inc. — Sellersville, PA

FDA drug recall D-128-2013 was initiated by Teva Pharmaceuticals USA, Inc. on Apr 24, 2012 and is designated Class III. Reason for recall: Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life The recall status is terminated (terminated Dec 18, 2013). Affected quantity: 13,232 bottles.

Recall details

Product Type
Drugs
Report Date
Jan 23, 2013
Initiation Date
Apr 24, 2012
Termination Date
Dec 18, 2013
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
13,232 bottles

Product description

CABERGOLINE Tablets, 0.5 mg, RX only, 8 count bottles, Manufactured For: TEVA PHARMACEUTICALS USA, Sellersville, PA 18960 NDC 0093-5420-88

Reason for recall

Impurities/Degradation Products: This lot of product will not meet the impurity specification over shelf life

Distribution pattern

Nationwide

Code information

Lot number 6A007046V, exp 07/12

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-128-2013
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-128-2013. Report a data issue: hello@regdatalab.com.